Effective July 9, 2018, the Kansas Board of Pharmacy added Date Sold (DSP17) to their prescription monitoring program, Kansas Tracking and Reporting of Controlled Substances (K-TRACS).
News: Legal & Regulatory
Pursuant to new legislation effective July 1, 2018, the Virginia Department of Health Professions prescription monitoring program (VA PMP) will now monitor the prescribing and dispensing of Schedule V drugs and naloxone.
Effective July 1, 2018, the Alaska Prescription Drug Monitoring Program (AK PDMP) will begin requiring dispensers to report controlled substance dispensations to the AK PDMP daily as of the previous submission date, as required in AS 17.30.200 and 12 AAC 52.865(b).
Effective July 1, 2018, the Maine Prescription Monitoring Program (ME PMP) requires reporting in ASAP 4.2A Standard and includes the following important changes.
Effective June 28, 2018, the Guam Prescription Drug Monitoring Program Database (GU PDMP) begins using a new vendor, PMP AWARxE™ maintained by Appriss, to provide prescription monitoring services for Guam.
NCPA Past President Sal D’Angelo was credited with the expression, “Get into politics or get out of pharmacy.” That was nearly 50 years ago when the National Community Pharmacists Association (NCPA) held its first legislative conference − one of the first such events in the profession. Even though times have changed, the importance of that message for pharmacy owners has not.
On December 18, South Carolina Governor Henry McMaster issued two executive orders regarding the opioid epidemic. As one result, by March 1, the organization that provides insurance for the state’s public employees will voluntarily adopt a five-day limitation on initial opioid prescriptions for acute and post-operative needs.
As of Monday, January 1, 2018, prescribers in Nevada must begin their controlled substance reporting in ASAP 4.2A format. You can find the specifications for 4.2A reporting on page 4 of the Nevada Data Submission Dispenser Guide, under the heading "Upload Specifications."
As of Friday, December 29, 2017, prescribers in Ohio must include the first four alphanumeric characters (e.g., M16.5) of the diagnosis code (ICD-10), or the full procedure code (Current Dental Terminology - CDT), on all opioid prescriptions, which will then be entered by pharmacies into OARRS (Ohio Automated Rx Reporting System).
Effective January 1, 2018, the Nebraska Prescription Drug Monitoring Program (PDMP) requires that all prescriptions be reported. You can find reporting requirements in the Nebraska Dispenser's Implementation Guide (version 3.6).